Jeena Sikho Lifecare Limited Releases Unaudited Financial Results for Q2 and H1 Ending September 30, 2026
Board approves standalone and consolidated results reviewed by statutory auditors without material concerns
Jeena Sikho Lifecare Limited reported its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, reviewed by statutory auditors Walker Chandiok & Co LLP with no material misstatements noted. The Board approved the financials in their meeting held on November 14, 2026.
Jeena Sikho Lifecare Limited
Financial Results
Jeena Sikho Lifecare Limited announced its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. These results were reviewed by Walker Chandiok & Co LLP, who found no material misstatements.
The Board of Directors approved the unaudited financial statements in their meeting held at the company’s registered office in Zirakpur, Punjab on November 14, 2026, from 4:45 p.m. to 6:05 p.m. IST.
The standalone and consolidated results comply with Indian Accounting Standard 34 (Ind AS 34) and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The Independent Auditor's Review Reports from Walker Chandiok & Co LLP concluded with no indications of material misstatements in the financial statements.
The consolidated results include financial information from the holding company and its subsidiaries, with partial information missing from two subsidiaries; however, no issues were noted.
The financial results have been made available on the company website www.jeenasikho.com for investor reference.
Highlights
- Unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026 approved.
- Board meeting held on November 14, 2026, in Zirakpur, Punjab.
- Review by Walker Chandiok & Co LLP found no material misstatements.
- Results prepared as per Ind AS 34 and SEBI Listing Regulations.
- Results published on the company’s website for public access.
Key Data Snapshot
What happened
- Jeena Sikho Lifecare Limited’s Board of Directors approved the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026.
- The results were approved in a board meeting held on November 14, 2026, at the company’s registered office in Zirakpur, Punjab.
- The unaudited results are in compliance with relevant Indian Accounting Standards and SEBI regulations.
Key details
- Audit and review of the financial results were conducted by Walker Chandiok & Co LLP.
- No material misstatements were found in the standalone and consolidated results during the review.
- The consolidated results include the holding company and its subsidiaries; some financial data from two subsidiaries was not reviewed but no concerns were reported.
- The full results and auditor reports have been made available on the company’s official website.
Regulatory and governance context
- The financial results were prepared under Indian Accounting Standard 34 (Interim Financial Reporting).
- Disclosures comply with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended.
- The reviews were conducted in compliance with Standard on Review Engagements (SRE) 2410 by the Institute of Chartered Accountants of India.
- Walker Chandiok & Co LLP holds firm registration number 001076N/N500013 and issued the review reports on November 14, 2026.
Next milestones
- Future financial disclosures will continue as per SEBI Listing Obligations and will be available on the company website and stock exchanges.
- The company will hold subsequent board meetings for review and approval of quarterly and annual results as per regulatory timelines.
Highlights
- Unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026 approved.
- Board meeting held on November 14, 2026, in Zirakpur, Punjab.
- Review by Walker Chandiok & Co LLP found no material misstatements.
- Results prepared as per Ind AS 34 and SEBI Listing Regulations.
- Results published on the company’s website for public access.
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- Indian Accounting Standard 34 (Interim Financial Reporting)
- Standard on Review Engagements (SRE) 2410
More News on Financial Results
View allLatest corporate announcements and market updates in Financial Results.
Balaji Telefilms Announces Unaudited Q2 and H1 Financial Results for September 30, 2026
Balaji Telefilms Limited has released its unaudited standalone and consolidated financial results for the quarter and six months ended September 30, 2026. The results were reviewed by the company's independent auditor Deloitte Haskins & Sells LLP and include financial data from its subsidiaries Balaji Motion Pictures Limited and Ding Infinity Private Limited.
Read Full StoryGenesys International Announces Q2 FY2027 Unaudited Financials and Grants 3.65 Lakh Employee Stock Options at Discounted Prices
Genesys International Corporation Limited disclosed its unaudited standalone and consolidated financial results for Q2 and H1 ended September 30, 2026, reporting a profit before tax of Rs.727.84 lakh in the quarter. The company also approved the grant of 3,65,000 employee stock options under its 2022 ESOP scheme, with exercise prices between Rs.70 to Rs.100, discounted significantly from the previous day's NSE closing price.
Read Full StoryShri Ram Apartment Development Co Ltd Submits Incomplete Filing with No Financial or Corporate Data
Shri Ram Apartment Development Co Ltd submitted a filing to BSE that only references annexures but does not contain any financial, corporate, or transactional information.
Read Full Story